Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-10

FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cayston (aztreonam) submitted by Gilead Sciences, Inc., marking approval of an updated or expanded use for the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cayston (aztreonam lysine)

Snippet

SUPPL AP for CAYSTON (AZTREONAM)